| Page 1450 | Kisaco Research
 
Phage Futures Europe 2019
25-26 Sep 2019
Brussels, Belgium
The inaugural Phage Futures Europe 2019 in Brussels, Belgium was the first of its kind in Europe to discuss how to translate phage-based application in to clinically and commercially viable therapeutics.Phage Futures Europe will return in 2020 to once again bring together representatives from established biotech companies (from human and animal applications), new adopters, key academic researchers and big pharma. You’ll take away actionable insights on:Preclinical data of phage therapy applications in acute and chronic indicationsThe importance of magistral preparation for the personalised modelRegulatory guidance to achieve data via magistral preparation or fixed cocktail methodsThe impact of phage on the immune systemAdministering phage therapy to overcome the current unmet medical need.Investment drivers"Investors and industry are displaying increased in interest in phage as a therapeutic modality. This conference is an unique opportunity to learn of this exciting modality." Assaf Oron, Chief Business Officer, BiomX
Visit Site
 

Linda Paeez

Strategy
Melico

Linda Paeez

Strategy
Melico

Linda Paeez

Strategy
Melico
 

Stacy House

VP Research & Innovation
KDC One Innovation Lab

Currently, Stacey House is the Vice President of R&D/Regulatory for KDC-One’s Beauty and Personal Care Division. Her talented teams at Acupac, Chemaid, Innovation Lab and Kolmar focus on developing elevated, high touch formulas in categories spanning the personal care industry. Previously, she was the Director of R&D at Mana Products, Director of Applications at Kobo Products, and had also worked in Coty and Revlon’s R&D labs. She holds a patent on Low Viscosity Phenyl Trimethicone Applications and has written several published industry articles.

Read full bio

Stacy House

VP Research & Innovation
KDC One Innovation Lab

Stacy House

VP Research & Innovation
KDC One Innovation Lab

Currently, Stacey House is the Vice President of R&D/Regulatory for KDC-One’s Beauty and Personal Care Division. Her talented teams at Acupac, Chemaid, Innovation Lab and Kolmar focus on developing elevated, high touch formulas in categories spanning the personal care industry. Previously, she was the Director of R&D at Mana Products, Director of Applications at Kobo Products, and had also worked in Coty and Revlon’s R&D labs. She holds a patent on Low Viscosity Phenyl Trimethicone Applications and has written several published industry articles. Stacey graduated from Northeastern University with MBAs in Operations, Supply Chain, and International Business and received her Bachelors of Science degree at Rutgers University-New Brunswick. She is an active member of CHIEF, CEW, and the NYSCC Scientific Committee.

 

Natalie Eden

Director, Client Success
OceanX

Natalie Eden

Director, Client Success
OceanX

Natalie Eden

Director, Client Success
OceanX
 

Kavitha Prasad

VP Business Development and Systems Applications
SiMa.ai

Kavitha Prasad is the Vice President of Business Development and Systems Applications at SiMa.ai. Through close collaboration with customers and partners, Kavitha is responsible for defining the system-level architecture for SiMa.ai's machine learning SoC. She is a technology leader with over 22 years of experience in delivering multiple successful products in ASICs, SoCs, FPGAs, and servers across multiple process nodes.

Read full bio

Kavitha Prasad

VP Business Development and Systems Applications
SiMa.ai

Kavitha Prasad

VP Business Development and Systems Applications
SiMa.ai

Kavitha Prasad is the Vice President of Business Development and Systems Applications at SiMa.ai. Through close collaboration with customers and partners, Kavitha is responsible for defining the system-level architecture for SiMa.ai's machine learning SoC. She is a technology leader with over 22 years of experience in delivering multiple successful products in ASICs, SoCs, FPGAs, and servers across multiple process nodes. Prior to SiMa.ai, Kavitha was responsible for system solutions across embedded market segments for the Intel Platform Solutions Group, among other positions at Intel. Prior to Intel she held multiple technology roles at Xilinx and Philips. Kavitha holds a Master of Science in Electrical and Electronics Engineering from San Jose State University.

Optimized SoC Hardware for Highly Efficient AI Systems

Forward-looking system and SoC architects are asking themselves: “What does the next generation of AI need?” Innovative companies are adopting approaches that offer flexible, future-proof adoption of new neural network models to function effectively on purpose-built ML devices. As tasks move from the cloud to the edge, each type of application requires workload-specific optimization of processing, memories, data movement, and security.

Join this webinar with Synopsys and SiMa.ai to learn:

 

Ron Lowman

AI Strategic Marketing Manager
Synopsys

Ron Lowman joined Synopsys in 2014 and is currently the AI Strategic Marketing Manager for the Solutions Group. Ron is responsible for driving Synopsys’ Artificial Intelligence market IP initiatives, including strategic business and market trend analysis.

Prior to joining Synopsys, Lowman spent 16 years at Motorola/Freescale in Controls Engineering, Automotive Product & Test Engineering, Product Management, Business Development, Operations, and Strategy Roles.

Read full bio

Ron Lowman

AI Strategic Marketing Manager
Synopsys

Ron Lowman

AI Strategic Marketing Manager
Synopsys

Ron Lowman joined Synopsys in 2014 and is currently the AI Strategic Marketing Manager for the Solutions Group. Ron is responsible for driving Synopsys’ Artificial Intelligence market IP initiatives, including strategic business and market trend analysis.

Prior to joining Synopsys, Lowman spent 16 years at Motorola/Freescale in Controls Engineering, Automotive Product & Test Engineering, Product Management, Business Development, Operations, and Strategy Roles.

Ron holds a Bachelor of Science in Electrical Engineering from Colorado School of Mines and an MBA from the University of Texas in Austin.

 
Microbiome Connect : Skin - USA
17-18 Nov 2021
COURTYARD BY MARRIOTT, BOSTON DOWNTOWN BOUTIQUE HOTEL
Love the skin you’re in? How about the bugs on it?Over the six years we’ve run Microbiome Connect: Skin, the field has changed drastically. In a short period, the field has gone from fringe to mainstream, from quantifying the size of bacterial populations to understanding their function. As the field continues to commercialize, it is time to ask how this research can benefit consumers. How can the skin microbiome be leveraged as a source of biomarkers, as a therapeutic modality, as an understandable term to consumers?Join us in Boston for a two-day face-to-face event, attended in the past by the likes of P&G, Jackson Laboratory, and the FDA. Unravel the function of the skin microbiome and apply the latest findings to your future products. See you in November!Here’s a sneak peek of some key takeaways:Establish skin microbiome friendly hygiene products to meet consumer demands related to the pandemic, with Codex Beauty and SanexFind out how to maintain regulatory standards and avoid litigation around claims with Q&A and presentations from FDA and NADDiscover how to use functional prebiotics to feed beneficial bacteria and increase product development price efficiency and convenience with Cybele Microbiome and Colgate PalmoliveTap into personalized skincare with pore specific Cutibacterium acnes data and analytics from Tami Lieberman and DermalaLeverage phage, LBP and autologous bactherapeutics to target skin disease with AOBiome, Azitra, Matrisys, BiomX and more"This event is a unique gathering of individuals from academia and industry who are collaborating to advance microbiome science. Kisaco has gone out of their way to include speakers and perspectives not found elsewhere. I look forward to attending again" KC Communications Group
Visit Site
 
Aquaculture Innovation Summit 2021
28-29 Sep 2021
Virtual Event
Showcasing the Most Exciting Innovation Across Nutrition, Health and Digital The Aquaculture Innovation Summit is back! Now in its 4th year, the Summit is a major part of the Animal Health Innovation series, which focuses on showcasing and supporting innovation and sustainability initiatives in three key areas of aquaculture: nutrition, health and digital.Our objective at this two-day event is to bring to light cutting-edge modern technologies and solutions that are helping shape one of the most important industries for the future of global protein. Throughout the on-demand and live parts of the agenda, key discussions in 2021 include:Digital transformation and how that can optimise aquacultureIdentifying the next steps to guarantee the future of sustainable and functional feedsThe hottest areas for investment from investors and big companiesThe future of health and genetics to improve performance and welfareEnsuring aquaculture is seen as part of a healthy, sustainable food systemDeep dive into land-based and open ocean as alternatives to in-shore, cage-based production
Visit Site
 

Jan Berger, M.D., M.J.

CEO, Health Intelligence Partners & Medical Director
Midwest Business Group on Health

Is a tri-sector healthcare executive with outstanding leadership experience in the three sectors of private, public and government services over the last 30 years. In 2009 Jan founded Health Intelligence Partners as a health care consultancy that blends more than thirty years of business and clinical experience.

Read full bio

Jan Berger, M.D., M.J.

CEO, Health Intelligence Partners & Medical Director
Midwest Business Group on Health

Jan Berger, M.D., M.J.

CEO, Health Intelligence Partners & Medical Director
Midwest Business Group on Health

Is a tri-sector healthcare executive with outstanding leadership experience in the three sectors of private, public and government services over the last 30 years. In 2009 Jan founded Health Intelligence Partners as a health care consultancy that blends more than thirty years of business and clinical experience. Health Intelligence Partners has a global focus (engagements in 14 countries with both Health Organizations and National Ministries of Health), helping clients to navigate the intersection of strategy and operations within both the healthcare and consumer goods and services environment in order to identify and articulate high value opportunities.

 

Prior to founding Health Intelligence Partners, Jan served as Senior Vice President, Chief Clinical Officer and Innovation Officer for CVS Health/Caremark. During that time, she was a corporate officer and on the executive team with P & L (500 million-dollar business unit), operations and strategic experience. Jan also lead Caremark’s Medicare Part D development and was the clinical lead for CVS Caremark’s M & A activity. During this time, Jan developed an expertise in both healthcare and retail consumer behavior.  Before going to CVS Caremark, Jan had 15 years’ experience in healthcare administration within the health plan and academic arenas and lead operations for two population health companies.

 

As a veteran healthcare executive, Jan’s leadership has delivered results in a variety of settings. Jan offers her experiences and insights through her consulting agency as well as through her participation on healthcare and consumer product boards. She presently sits on healthcare focused boards including), GNS Healthcare (Vice Chair of the Board, Chair; Governance/Compensation/Nomination Committee, M&A/Strategy Committee), Cambia Health Solutions (Consumer Engagement Platform Committee, Health Services Committee), Tabula Rasa (Nominations, Compensation, Governance), UCB Pharmaceuticals and Voluntis Health Care (Chair, M&A/Strategy Committee). Jan’s consumer focused boards have included Savor Health, Care Heroes and Whiskerdocs. Jan previous board experience includes; Care Core National (Committees: Audit and Finance Committee, Compensation, Search, M&A and Strategic Directions), AccentCare (Chair; Compliance Committee, Compensation Committee), Qliance and Rx-Ante. She also sits on numerous business and healthcare advisory boards.

 

As the author of the books “Leveraging Health”, “Thirteen Common Pitfalls in Consumer Engagement”, “We Don’t Talk Anymore: A Consumer’s Guide to Connecting with their Doctor” and “Medical Liability for Pediatricians”, the past Editor in Chief of American Journal of Pharmacy Benefit and on the editorial boards of a number of healthcare journals, Jan is considered a national health care thought leader. Jan speaks and writes on a broad range of health care and pharmaceutical services issues.

 

Jan holds both a Doctor of Medicine degree and a master’s degree in jurisprudence from Loyola University in Chicago, and a Certificate in Healthcare Business Administration from University of South Florida. She also holds a black belt in Six Sigma. Jan is an assistant professor at Northwestern University School of Medicine and School of Communication in Chicago, Illinois where she teaches the Engaging the Consumer in Health course.